Clinical Trials on Hiperoxaluria primaria tipo 2
Total 131 results
-
Dicerna Pharmaceuticals, Inc.CompletedKidney Diseases | Urologic Diseases | Genetic Disease | Primary Hyperoxaluria Type 1 (PH1) | Primary Hyperoxaluria Type 2 (PH2)Poland, United Kingdom, New Zealand, United States, Australia, Canada, France, Germany, Israel, Italy, Japan, Lebanon, Netherlands, Romania, Spain
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyEnrolling by invitationKidney Diseases | Urologic Diseases | Genetic Disease | Primary Hyperoxaluria Type 1 (PH1) | Primary Hyperoxaluria Type 2 (PH2) | Primary Hyperoxaluria Type 3 (PH3)United States, France, Germany, Japan, Lebanon, Spain, United Kingdom, Australia, Canada, Italy, Netherlands, Norway, Turkey
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyRecruitingPrimary Hyperoxaluria Type 3 | Primary Hyperoxaluria Type 2 | Primary Hyperoxaluria Type 1 | Primary HyperoxaluriaUnited States, Canada, Lebanon, Turkey, United Kingdom, Germany, Italy, Japan, Poland, Spain, United Arab Emirates
-
Alnylam PharmaceuticalsCompletedPrimary Hyperoxaluria Type 1 (PH1)France, United Kingdom, Netherlands, Israel, Germany
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyRecruitingEnd Stage Renal Disease | Primary Hyperoxaluria Type 2 | Primary Hyperoxaluria Type 1Germany, Spain, United States, United Kingdom, Italy, United Arab Emirates, Lebanon, Morocco, France, Romania
-
VA New York Harbor Healthcare SystemMayo Clinic; New York UniversityUnknownOxalate, Primary Hyperoxaluria, MicrobiomeUnited States
-
Dicerna Pharmaceuticals, Inc.CompletedPrimary Hyperoxaluria Type 3United States, Germany, Netherlands, United Kingdom
-
University of CologneCompletedPrimary Hyperoxaluria Type IGermany
-
Alnylam PharmaceuticalsActive, not recruitingPrimary Hyperoxaluria Type 1 (PH1) | Primary HyperoxaluriaUnited States, France, United Kingdom, Israel, Germany
-
Alnylam PharmaceuticalsCompletedPrimary Hyperoxaluria Type 1 (PH1)United States, France, United Kingdom, Switzerland, Netherlands, Israel, Germany, United Arab Emirates
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyAvailablePrimary Hyperoxaluria Type 1 (PH1)
-
Dicerna Pharmaceuticals, Inc.TerminatedPrimary Hyperoxaluria Type 1Netherlands, Germany
-
Ann & Robert H Lurie Children's Hospital of ChicagoMayo Clinic; National Institute of Diabetes and Digestive and Kidney Diseases...CompletedPrimary Hyperoxaluria Type 1
-
Hospices Civils de LyonCompletedIdiopathic Hypercalciuria | Primary Hyperoxaluria Type 1France
-
Allena PharmaceuticalsCompletedEnteric Hyperoxaluria | Primary Hyperoxaluria | HyperoxalemiaUnited States, United Kingdom, Germany
-
Alnylam PharmaceuticalsActive, not recruitingPrimary Hyperoxaluria Type 1 | Primary HyperoxaluriaUnited States, Italy, France, Lebanon, Belgium, Netherlands, Israel, United Arab Emirates, Australia, Jordan, Turkey
-
Alnylam PharmaceuticalsRecruitingPrimary Hyperoxaluria Type 1France, Spain, United States, Israel, Belgium, Switzerland, Germany, United Kingdom, Italy, Canada
-
OxTheraCompletedPrimary HyperoxaluriaFrance, United Kingdom, Spain, Belgium, United States, Germany, Tunisia
-
BiocodexCompletedPrimary HyperoxaluriaFrance
-
OxTheraFP7-SME-2013 Research for the benefit of SMEs programCompletedPrimary HyperoxaluriaFrance, Germany, United Kingdom
-
Mayo ClinicNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Orphan...CompletedHyperoxaluriaUnited States
-
OxTheraTerminatedHyperoxaluria, PrimaryUnited Kingdom, Spain, Belgium, United States, Germany, Tunisia
-
Mayo ClinicCompleted
-
Mayo ClinicNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Oxalosis...Completed
-
Mayo ClinicNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Withdrawn
-
OxTheraFP7-SME-2013 Research for the benefit of SMEs programCompletedPrimary HyperoxaluriaGermany
-
Dicerna Pharmaceuticals, Inc.CompletedPrimary HyperoxaluriaUnited States, France, Germany, Netherlands, United Kingdom
-
OxTheraCompletedPrimary HyperoxaluriaUnited States
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyActive, not recruitingPrimary Hyperoxaluria Type 3United States, Germany, United Kingdom, Canada, Poland
-
Cystinose StiftungScreening Laboratory Hannover; Pediatry Kastanienhof Koeln; Medical Genetics... and other collaboratorsRecruitingCystinosis | Primary HyperoxaluriaGermany
-
University Hospital, Strasbourg, FranceRecruiting
-
Hospices Civils de LyonRecruitingPatients With PH1 Treated With Lumasiran in FranceFrance
-
Alnylam PharmaceuticalsApproved for marketingPrimary HyperoxaluriaBelgium
-
Alnylam PharmaceuticalsCompletedPrimary Hyperoxaluria | PH1 | RNAi Therapeutic | siRNA | AGTFrance, United Kingdom, Netherlands, Israel, Germany
-
Mayo ClinicNational Institutes of Health (NIH); Oxalosis and Hyperoxaluria Foundation...WithdrawnKidney Stones | Nephrocalcinosis | Primary HyperoxaluriaUnited States
-
NYU Langone HealthNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedCystinuria | Primary Hyperoxaluria | Dent Disease | Adenine Phosphoribosyl Transferase DeficiencyUnited States, Iceland
-
Mayo ClinicRecruitingCystinuria | Primary Hyperoxaluria | Dent Disease | APRT DeficiencyUnited States
-
Mayo ClinicNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National... and other collaboratorsRecruitingCystinuria | Primary Hyperoxaluria | Dent Disease | APRT DeficiencyUnited States, Iceland
-
NORCE Norwegian Research Centre ASNorwegian Labour and Welfare AdministrationCompletedAll International Classification of Primary Care 2 DiagnosesNorway
-
Gruppo Italiano Malattie EMatologiche dell'AdultoCompletedAdult Patients | Immune Primary Thrombocytopenia | Splenectomy | TPO-mimeticsItaly
-
University of Texas Southwestern Medical CenterCompletedPrimary Disease: 1. Type 2 DiabetesUnited States
-
German Diabetes CenterGerman Institute of Human Nutrition; Association of Statutory Health Insurance...CompletedType 2 Diabetes Mellitus | Primary PreventionGermany
-
The Cleveland ClinicRecruitingPrimary Hyperparathyroidism | Type 2 DiabetesUnited States
-
Rambam Health Care CampusTechnion, Israel Institute of TechnologyUnknownGroup 1: Trauma Operation for Otherwise Healthy Patients | Group 2: Primary Tumors of Mesenchymal OriginIsrael
-
Basque Health ServiceCompletedRandomized Controlled Trial | Interprofessional Relations | Primary Health Care/Organization & Administration | Diabetes Mellitus, Type 2/Prevention & Control | Primary Prevention/Methods | Risk Reduction Behavior | Life StyleSpain
-
Province of Malaga Health DepartmentRoche Diagnostics Spain (Diabetes Care)CompletedType 2 Diabetes | Telemedicine | Primary Care | Self Monitoring Blood GlucoseSpain
-
University of AkureyriWestern Norway University of Applied SciencesCompletedCardiovascular Risk Factor | Primary Health Care | Pre-diabetes | T2DM (Type 2 Diabetes Mellitus)Iceland
-
US Department of Veterans AffairsCompletedDiabetes Mellitus, Type 1 | Diabetes Mellitus Type 2 | Primary Care ProviderUnited States
-
QualiCCareNovo Nordisk A/S; Sanofi; Swiss Society of Endocrinology and Diabetology; Roche... and other collaboratorsCompletedDiabetes Mellitus, Type 2 | Primary CareSwitzerland